4.6 Article

Laboratory and field studies to investigate the efficacy of a novel, orally administered combination product containing moxidectin, sarolaner and pyrantel for the prevention of heartworm disease (Dirofilaria immitis) in dogs

Related references

Note: Only part of the references are listed.
Article Parasitology

Perspectives on the utility of moxidectin for the control of parasitic nematodes in the face of developing anthelmintic resistance

Roger K. Prichard et al.

INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2019)

Review Microbiology

Human and Animal Dirofilariasis: the Emergence of a Zoonotic Mosaic

Fernando Simon et al.

CLINICAL MICROBIOLOGY REVIEWS (2012)

Review Parasitology

Pet roundworms and hookworms: A continuing need for global worming

Donato Traversa

PARASITES & VECTORS (2012)

Review Parasitology

Moxidectin and the avermectins: Consanguinity but not identity

Roger Prichard et al.

INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2012)

Article Veterinary Sciences

Ivermectin and Milbemycin Oxime in Experimental Adult Heartworm (Dirofilaria immitis) Infection of Dogs

D. E. Snyder et al.

JOURNAL OF VETERINARY INTERNAL MEDICINE (2011)

Article Pharmacology & Pharmacy

Estimation of absolute oral bioavailability of moxidectin in dogs using a semi-simultaneous method: influence of lipid co-administration

E. Lallemand et al.

JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2007)

Article Veterinary Sciences

Safety of moxidectin in avermectin-sensitive collies

AJ Paul et al.

AMERICAN JOURNAL OF VETERINARY RESEARCH (2000)